The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

A Multidisciplinary Toxicity Team for Cancer Immunotherapy–Related Adverse Events

(2019) Jarushka Naidoo et al.   Journal of the National Comprehensive Cancer Network

Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities

(2018) Karthik Suresh et al.   CHEST

Pneumonitis in Non-Small Cell Lung Cancer patients receiving Immune Checkpoint Immunotherapy: incidence and risk factors

(2018) Karthik Suresh et al.   Journal of Thoracic Oncology

Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

(2018) Jun Yeun Cho et al.   LUNG CANCER

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression

(2018) Elena Gianchecchi et al.   Frontiers in Immunology

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy

(2018) Karthik Suresh et al.   Journal of Thoracic Oncology

Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

(2017) Jarushka Naidoo et al.   JOURNAL OF CLINICAL ONCOLOGY

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

(2017) Matthew D Hellmann et al.   LANCET ONCOLOGY

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

(2017) I. Puzanov et al.   Journal for ImmunoTherapy of Cancer

Regulatory T Cell DNA Methyltransferase Inhibition Accelerates Resolution of Lung Inflammation

(2015) Benjamin D. Singer et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data

(2015) Sofie Van Gassen et al.   CYTOMETRY PART A

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

(2015) Julie Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antagonists of PD-1 and PD-L1 in Cancer Treatment

(2015) Evan J. Lipson et al.   SEMINARS IN ONCOLOGY

Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab

(2015) S. H. Tirumani et al.   Cancer Immunology Research

CD11b+ Myeloid Cells Are the Key Mediators of Th2 Cell Homing into the Airway in Allergic Inflammation

(2014) B. D. Medoff et al.   JOURNAL OF IMMUNOLOGY

Foxp3+ regulatory T cells promote lung epithelial proliferation

(2014) J R Mock et al.   Mucosal Immunology

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

(2013) Lloyd Mayer et al.   GUT

An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

(2012) Keith C. Meyer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes

(2012) Jung Hwan Sung et al.   CELL

Resolution of Experimental Lung Injury by Monocyte-Derived Inducible Nitric Oxide Synthase

(2012) F. R. D'Alessio et al.   JOURNAL OF IMMUNOLOGY

Understanding the mechanism of IL-1β secretion

(2011) Gloria Lopez-Castejon et al.   CYTOKINE & GROWTH FACTOR REVIEWS

flowCore: a Bioconductor package for high throughput flow cytometry

(2009) Florian Hahne et al.   BMC BIOINFORMATICS

Treatments for pulmonary sarcoidosis

(2008) Dennis K. Heffner   RESPIRATORY MEDICINE